CAMBRIDGE, MA – September 22, 2022 - Arbor Biotechnologies®, a biotechnology company discovering and developing the next generation of genetic medicines, today announced its participation in upcoming healthcare investor conferences in September and October.
Conference Details:
| Event: |
Jefferies Cell & Genetic Medicine Summit |
| Date/Time: |
Thursday, September 29th at 8:30 a.m. ET |
| Location: |
New York, NY |
| Format: |
Corporate Presentation |
| Event: |
Chardan 6th Annual Genetic Medicines Conference |
| Date/Time: |
Monday, October 3rd at 9:30 a.m. ET and 11:30 a.m. ET |
| Location: |
New York, NY |
| Format: |
Panel and Corporate Presentation, respectively |
| Event: |
BMO Biopharma Spotlight Series: Gene Editing & Therapeutics |
| Date/Time: |
Thursday, October 6th at 12:00 p.m. ET |
| Location: |
Virtual |
| Format: |
Panel |
| Event: |
Oppenheimer Private Company Showcase |
| Date/Time: |
Tuesday, October 18th at 2:10 p.m. PT |
| Location: |
Palo Alto, CA |
| Format: |
Corporate Presentation |
A webcast of the Jefferies Cell & Genetic Medicine Summit presentation will be accessible through the News Section of the company’s website at www.arbor.bio, with a replay available for 90 days following the event.
